Systemic sclerosis (scleroderma): open trials in Norway

1 open trial has a site in Norway. Registry data; only the trial team decides who can take part.

NCT06195072
A study of different investigational treatments in people with the interstitial lung disease that accompanies scleroderma (CONQUEST)
Trial Treatment · Phase 2 · Scleroderma Research Foundation
Oslo University Hospital HF, Oslo · Universitetssykehuset Nord-Norge HF, Tromsoe
Registry updated 2026-10-08

This page is not medical advice. Talk to your doctor before contacting a trial.

A study of different investigational treatments in people with the interstitial lung disease that accompanies scleroderma (CONQUEST)